Abstract: |
The demand for innovative drug dosing devices has surged in recent years, driven by the rapid development of novel biological drugs that require customized and precise administration methods. With the introduction of complex biologics, such as monoclonal antibodies and gene therapies, there is a growing need for dosing systems that can efficiently handle high-viscosity drugs and deliver accurate dosages. This has raised significant challenges for conventional drug delivery mechanisms, particularly in the context of two widely used methods: short-term subcutaneous drug infusion and long-term implantable drug infusion systems. However, these drugs, often embedded in viscous matrices up to 25 times the viscosity of water. Conventional dosing systems quickly reach their limits, as these viscous liquids cause an extremely large pressure drop on the thin injection needles, leading to inconsistent dosing, device wear, and even system failure. This research focuses on the development of miniaturized metal-based piezoelectric micropumps capable of overcoming the challenges associated with high-viscosity drug administration along with high force generating actuators to generate the precise, controlled movement required to pump high-viscosity fluids. In addition to the inherent challenges of dosing high-viscosity drugs, external disturbances such as presence of air bubbles, catheter blockages, kinking of tubes, and delamination of piezoceramic actuators can lead to dosing errors. Therefore, this research also focuses on developing techniques to monitor the potential failure states by incorporating sensing capabilities into the dosing device to identify deviations from normal function, such as changes in pump chamber pressure or net flow rate and activating corrective measures in real-time. This approach facilitates the creation of a closed-loop control system for the microdosing device, enhancing both its reliability and safety. |